Skip to main content
. 2022 Jan 20;58(2):158. doi: 10.3390/medicina58020158

Table 2.

Clinical characteristics and laboratory data in patients with liver cirrhosis.

Variables Total Patients (n = 386)
Sex (m/f) 309/77
Age (years) 62.4 ± 13.14
Etiology, n (%)
Alcohol 273 (70.7)
Hepatitis B virus 17 (4.4)
Hepatitis C virus 18 (4.7)
Autoimmune disease 26 (6.7)
Wilson disease 3 (0.8)
Toxic 3 (0.8)
Cryptogenic 52 (13.5)
Laboratory test
Hb (g/L) a 111.10 ± 81.62
WBC (109/L) a 9.35 ± 5.23
PLT (109/L) a 129.887 ± 85.65
TBIL (mmol/L) b 81 (100)
Alb (g/L) b 27 (5)
AST (U/L) b 82 (97)
ALT (U/L) b 31 (27)
ALP (U/L) b 156 (213)
GGT (U/L) b 68 (1590)
BUN (mmol/ L) b 13.2 (25)
Cr (µmol/L) b 115 (268)
INR b 1.7 (1.78)
D-dimer (mg/L) b 6.18 (28.1)
CRP (mg/L) b 43.5 (127)
Pct (ng/L) b 3.0 (12.7)
Na (mmol/L) b 136.20 ± 6.14
K (mmol/L) b 4.28 ± 0.92
LDH (U/L) b 675 (1168)
NH4 (µmol/L) b 89 (59)
Cholesterol (mmol/L) 3.30 ± 1.97
Triglycerides (mmol/L) 1.27 ± 0.82
MELD score b 16.4 (13.5)
APRI score b 1.48 (2.64)
AAR score b 1.9 (1.12)
FIB-4 score b 6.15 (7.66)
King score b 1036 (1841.28)
FI score b 4.1 (1.33)
Loc score b 4.08 (3.97)
ALBI score b −1.11 (0.89)
PALBI score b −1.54 (0.66)
ABIC score b 8.43 (2.15)

Abbreviations: a mean ± SD, b median(IQR), pts—patients, n—number of patients, Hb—hemoglobin, WBC—white blood cell, Plt—platelet, TBil—total bilirubin, Alb—albumin, AST—aspartate aminotransferase, ALT—alanine aminotransferase, ALP—alkaline phosphatase, GGT—gamma glutamyltransferase, BUN—blood urea nitrogen, Cr—creatinine, INR—international normalized ratio, CRP—C-reactive protein, Pct—procalcitonin, Na—sodium, K—potassium, LDH—lactic acid dehydrogenase, NH4—ammonium ion, MELD—model for end-stage liver disease, APRI—AST to platelet ratio index, AAR—aspartate aminotransferase-to-alanine aminotransferase ratio, FIB—fibrosis-4 index, FI—fibrosis index, ALBI—albumin-bilirubin, PALBI—platelet-albumin-bilirubin, ABIC—Age, bilirubin, INR, creatinine score.